Trial Profile
Case-control Study to Evaluate the Vaccine Effectiveness of Rotarix Against Rotavirus Severe Gastroenteritis (RV SGE) Among Hospitalized Children Born After 6 March 2006 and at Least 12 Weeks of Age, in Belem, Brazil.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 30 Aug 2023
Price :
$35
*
At a glance
- Drugs RIX 4414 (Primary)
- Indications Gastroenteritis; Rotavirus infections
- Focus Registrational; Therapeutic Use
- Sponsors GlaxoSmithKline; GSK
- 03 Jun 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 24 Aug 2010 New trial record